Clinical Trial Update: Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study [NA]

View source ↗

Summary

This entry describes a randomized medico-economic study investigating whether remission evaluation by FDG-PET influences subsequent treatment decisions in lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Lymphoma | NA | Status: UNKNOWN